血压监测设备市场－全球产业规模、份额、趋势、机会及预测（依产品类型、技术、最终用户、地区及竞争格局划分，2021-2031年）

全球血压监测设备市场预计将从 2025 年的 28.2 亿美元成长到 2031 年的 43.5 亿美元，复合年增长率为 7.49%。

这些诊断设备涵盖了从手动血压计到自动数位血压计等各种类型，既可用于医疗用途，也可用于个人，其设计目的都是为了测量动脉血压。推动该市场成长的因素有二：一是全球慢性心血管疾病盛行率不断上升，二是人口老化速度加快，这两方面都要求人们频繁进行健康评估，以预防急性医疗事件的发生。例如，世界卫生组织（WHO）估计，到2024年，全球将有14亿30至79岁的成年人患有高血压，凸显了对有效检测工具的巨大需求。

然而，阻碍市场发展的一大障碍是，在非受控临床环境下使用的自动血压监测仪的准确性存在差异。这些测量结果与专业标准之间的差异可能导致误诊，并削弱医疗专业人员对患者自述数据的信任。此外，遵守复杂的监管核准流程以及满足不同国际司法管辖区的严格检验标准也构成了巨大的准入门槛，最终将减缓经济实惠的监测解决方案的广泛应用。

市场驱动因素

全球高血压和心血管疾病盛行率的不断上升是血压监测设备市场的主要驱动力。这种激增与肥胖和缺乏运动等生活方式相关的风险因素密切相关，从而推动了临床和家庭环境中对精准诊断工具的需求。随着慢性病负担的加重，医疗保健系统更加重视早期发现和持续管理，以降低中风和心臟衰竭等严重后果的发生率。根据美国心臟协会于2024年1月发布的《2024年心臟病和中风统计数据》的重点内容，美国约有1.224亿成年人患有高血压，这凸显了为不断增长的患者群体提供广泛可用的监测解决方案的迫切需求。

同时，远端患者监护（RPM）和远端医疗基础设施的成长正在改变市场动态，将医疗保健从医院转移到个人场所。无线数据传输技术整合到监护设备中，使医生能够即时追踪患者的生命体征并主动调整治疗方案，从而推动了这一趋势。此类数位健康工具的应用正成为现代医疗实践的结构性组成部分。根据美国医学会（AMA）于2024年1月发布的《2024年数位健康调查》，20.3%的医师表示使用远端患者监护工具，是2018年的两倍。这种向互联医疗的转变也体现在全球分销量上。Omron Corporation在2024年9月发布的《2024年综合报告》中指出，2023财年全球血压计销售量达2,246万台。

市场挑战

在非受控临床环境下使用的自动血压监测仪的准确性存在差异，这是血压测量设备市场扩张的主要障碍。当个人监测设备读数与专家基准值不一致时，医疗专业人员会对患者自测资料的可靠性产生严重担忧，进而影响诊断决策。这种疑虑直接降低了医疗专业人员开立或建议家用血压监测方案的意愿，从而阻碍了这些技术的广泛应用。

根据美国医学会 (AMA) 2024 年的数据，美国主要电商平台上销售的血压计中，约有 80% 未经临床检验。如此高的未经检验率削弱了消费者的信任，并造成了市场分散，使得值得信赖的认证製造商难以与低品质的替代品竞争。因此，零售产品测量准确性的一致性无法保证，限制了市场将其全面融入标准慢性病管理通讯协定的能力，并阻碍了合规製造商的收入成长。

市场趋势

无袖带穿戴式生物辨识技术的出现正在革新市场，它无需传统充气袖带带来的不适感，即可实现连续、非侵入性的血压监测。这些设备利用光学感测器和专有演算法测量手腕或手指的讯号，提供全天候数据，包括夜间血压下降和波动，而这些往往是间歇性测量所无法捕捉到的。这项创新解决了患者依从性这一关键难题，其被动式设计鼓励用户持续佩戴，并产生纵向数据集，从而实现更精准的高血压管理。根据 Fit Insider 2025 年 5 月发表的题为「Aktiia 为下一代血压技术筹集 4,200 万美元」的报导报道，瑞士製造商 Hilo（前身为 Aktiia）已在全球 40 多个国家/地区售出超过 12 万台无袖带血压计，这表明该光学测量解决方案具有商业性可行性，且消费者需求日益增长。

此外，人工智慧 (AI) 在预测性高血压分析中的应用，正将设备从单纯的测量工具转变为全面的心血管风险评估平台。製造商正将机器学习演算法直接整合到监测系统中，以分析血压脉搏波的异常情况，从而在标准血压测量的基础上，早期发现诸如房颤等合併症。这项技术进步为患者和医生提供了可操作的见解，有助于在急性心血管事件发生前进行主动干预。根据Omron Healthcare于 2025 年 5 月发布的新闻稿《Omron Healthcare利用人工智能驱动的房颤检测技术革新血压测量体验》，该公司新型监测仪中的 IntelliSense 人工智能算法在临床试验中检测房颤的灵敏度达到 95%，特异性达到 98%，为家用诊断的准确度树立了新的标准准确性。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球血压监测设备市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类型（数位血压计、血压计、感测器、其他）
  • 按技术（数位、安卓、穿戴式装置）
  • 按最终使用者（医院/诊所、门诊手术中心、居家医疗、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美血压监测设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

第七章 欧洲血压监测设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区血压监测设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章 中东和非洲血压监测设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲血压监测设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球血压监测设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Omron Corporation
• A&D Medical Inc.
• Philips Healthcare
• Hillrom, Inc.
• General Electric Company
• Panasonic Corporation
• Microlife Corporation
• Beurer GmbH
• SunTech Medical, Inc.
• iHealth Labs, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Blood Pressure Monitoring Devices Market is projected to expand from a valuation of USD 2.82 Billion in 2025 to USD 4.35 Billion by 2031, reflecting a compound annual growth rate of 7.49%. These diagnostic instruments, which include manual sphygmomanometers and automated digital systems for both professional and personal use, are designed to measure arterial pressure. The market is fundamentally underpinned by the escalating global prevalence of chronic cardiovascular conditions and a rapidly aging population, both of which necessitate frequent health assessments to prevent acute medical incidents. For instance, the World Health Organization estimated in 2024 that 1.4 billion adults aged 30 to 79 years worldwide were living with hypertension, emphasizing the critical demand for effective detection tools.

However, a significant obstacle that could hinder market progression involves the accuracy variances observed in automated monitors utilized outside of controlled clinical environments. Discrepancies between these readings and professional standards can lead to incorrect diagnoses and diminish trust among healthcare providers regarding patient-generated data. Furthermore, navigating complex regulatory approval pathways and adhering to stringent validation standards across various international jurisdictions presents substantial barriers to entry, ultimately delaying the distribution of affordable monitoring solutions.

Market Driver

The increasing global prevalence of hypertension and cardiovascular diseases serves as a primary catalyst driving the blood pressure monitoring devices market. This surge is closely tied to lifestyle-related risk factors, such as obesity and sedentary behavior, which are intensifying the demand for accurate diagnostic tools in both clinical and home settings. As the burden of chronic conditions grows, healthcare systems are prioritizing early detection and consistent management to mitigate severe outcomes like stroke and heart failure. Highlights from the American Heart Association's "Heart Disease and Stroke Statistics-2024 Update" in January 2024 reveal that approximately 122.4 million adults in the United States had high blood pressure, underscoring the critical need for widely accessible monitoring solutions to address this expanding patient pool.

Simultaneously, the growth of remote patient monitoring (RPM) and telehealth infrastructure is reshaping market dynamics by transitioning care from hospitals to personal environments. This driver is supported by the integration of wireless data transmission in monitoring devices, enabling physicians to track patient vitals in real-time and adjust treatments proactively. The adoption of these digital health tools has become a structural component of modern medical practice; the American Medical Association's "2024 Digital Health Study" in January 2024 noted that 20.3 percent of physicians reported using remote patient monitoring tools, twice the rate observed in 2018. This shift toward connected care is reflected in global distribution volumes, with Omron Corporation reporting in September 2024, via their "Integrated Report 2024," global sales of 22.46 million blood pressure monitors for fiscal year 2023.

Market Challenge

Accuracy variances found in automated monitors used outside controlled clinical environments constitute a primary obstacle to the expansion of the blood pressure monitoring devices market. When personal monitoring devices produce inconsistent readings compared to professional references, it creates significant hesitation among healthcare practitioners regarding the reliability of patient-generated data for diagnostic decisions. This skepticism directly reduces the willingness of medical professionals to prescribe or recommend home monitoring solutions, thereby stifling the broader adoption of these technologies.

According to 2024 data from the American Medical Association, approximately 80 percent of blood pressure devices sold through major e-commerce sites in the United States had not been clinically validated for accuracy. Such high rates of non-validation undermine consumer confidence and create a fractured market environment where reliable, certified manufacturers struggle to compete against lower-quality alternatives. Consequently, the inability to guarantee consistent measurement precision across all retail products limits the market's potential to fully integrate into standard chronic disease management protocols and impedes revenue growth for compliant manufacturers.

Market Trends

The emergence of cuffless wearable bio-sensing technologies is revolutionizing the market by enabling continuous, non-invasive blood pressure tracking without the discomfort of traditional inflatable cuffs. These devices utilize optical sensors and proprietary algorithms to measure signals from the wrist or finger, providing 24/7 data that captures nocturnal dips and variability often missed by sporadic spot-checks. This shift addresses the critical issue of patient compliance, as the passive nature of the technology encourages sustained usage and generates longitudinal data sets for more accurate hypertension management. As reported by Fitt Insider in May 2025, in the article "Aktiia Scores $42M for Next-Gen Blood Pressure Tech," Swiss manufacturer Hilo (formerly Aktiia) has successfully sold over 120,000 cuffless monitoring devices across 40 countries, validating the growing commercial viability and consumer demand for these optical measurement solutions.

Furthermore, the integration of artificial intelligence for predictive hypertension analytics is transforming devices from simple measurement tools into comprehensive cardiovascular risk assessment platforms. Manufacturers are embedding machine learning algorithms directly into monitoring systems to analyze pressure pulse waves for irregularities, allowing for the early detection of comorbidities such as atrial fibrillation alongside standard blood pressure readings. This technological advancement empowers patients and physicians with actionable insights, facilitating proactive interventions before acute cardiac events occur. According to OMRON Healthcare's May 2025 press release, "OMRON Healthcare Evolves the Blood Pressuring Experience with AI-powered AFib detection," their new monitors featuring the IntelliSense AI algorithm demonstrated a 95 percent sensitivity and 98 percent specificity for detecting atrial fibrillation in clinical studies, establishing a new standard for home-based diagnostic accuracy.

Key Market Players

• Omron Corporation
• A&D Medical Inc.
• Philips Healthcare
• Hillrom, Inc.
• General Electric Company
• Panasonic Corporation
• Microlife Corporation
• Beurer GmbH
• SunTech Medical, Inc.
• iHealth Labs, Inc.

Report Scope

In this report, the Global Blood Pressure Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Pressure Monitoring Devices Market, By Product Type

• Digital Blood Pressure Monitor
• Sphygmomanometer
• Transducers
• Others

Blood Pressure Monitoring Devices Market, By Technology

• Digital
• Android
• Wearable

Blood Pressure Monitoring Devices Market, By End User

• Hospitals & Clinics
• Ambulatory Surgery Centres
• Home Care
• Others

Blood Pressure Monitoring Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Pressure Monitoring Devices Market.

Available Customizations:

Global Blood Pressure Monitoring Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Pressure Monitoring Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Digital Blood Pressure Monitor, Sphygmomanometer, Transducers, Others)
  • 5.2.2. By Technology (Digital, Android, Wearable)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centres, Home Care, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Blood Pressure Monitoring Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Technology
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Pressure Monitoring Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Blood Pressure Monitoring Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Blood Pressure Monitoring Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By End User

7. Europe Blood Pressure Monitoring Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Technology
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blood Pressure Monitoring Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By End User
  • 7.3.2. France Blood Pressure Monitoring Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Blood Pressure Monitoring Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Blood Pressure Monitoring Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Blood Pressure Monitoring Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By End User

8. Asia Pacific Blood Pressure Monitoring Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Technology
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Pressure Monitoring Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By End User
  • 8.3.2. India Blood Pressure Monitoring Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Blood Pressure Monitoring Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Blood Pressure Monitoring Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Blood Pressure Monitoring Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By End User

9. Middle East & Africa Blood Pressure Monitoring Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Technology
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Blood Pressure Monitoring Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Blood Pressure Monitoring Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Blood Pressure Monitoring Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By End User

10. South America Blood Pressure Monitoring Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Technology
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Blood Pressure Monitoring Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Blood Pressure Monitoring Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Blood Pressure Monitoring Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Blood Pressure Monitoring Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Omron Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. A&D Medical Inc.
• 15.3. Philips Healthcare
• 15.4. Hillrom, Inc.
• 15.5. General Electric Company
• 15.6. Panasonic Corporation
• 15.7. Microlife Corporation
• 15.8. Beurer GmbH
• 15.9. SunTech Medical, Inc.
• 15.10. iHealth Labs, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer